Synthesis of ccr5 receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) C07D 211/26 (2006.01)

Patent

CA 2594114

The present invention is directed to the synthesis of 4-[4-[(R)-[1- [cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1- piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine], and intermediates therefor from readily available starting materials by a novel route.

La présente invention concerne la synthèse de 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-pipéridinyl](3-fluorophényl)méthyl]-3(S)-méthyl-1-pipérazinyl]-1-[(4,6-diméthyl-5-pyrimidinyl)carbonyl]-4-méthylpipéridine], ainsi que des intermédiaires correspondants à partir de matériaux de départ facilement disponibles par une nouvelle voie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Synthesis of ccr5 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthesis of ccr5 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of ccr5 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1383193

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.